Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018)

Xtant Medical Holdings (XTNT) has disclosed Restructuring Costs for 2 consecutive years, with $388000.0 as the latest value for Q4 2018.

  • On a quarterly basis, Restructuring Costs fell 79.21% to $388000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $3.0 million, a 13.37% decrease, with the full-year FY2018 number at $3.0 million, down 36.54% from a year prior.
  • Restructuring Costs was $388000.0 for Q4 2018 at Xtant Medical Holdings, down from $614000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.9 million in Q4 2017 to a low of $380548.0 in Q2 2017.